 |
Chairman and President
Yuet Kan, M.D.
University of California, San Francisco
San Francisco, CA
Dr. Kan is the Louis K. Diamond professor of hematology at the University of California – San Francisco. He is regarded as a pioneer of applying molecular biology and genetics into clinical medicine. Kan was the first to establish that a single DNA mutation could lead to a human disease and the first to diagnose a human disease by using DNA. He also discovered DNA polymorphism, which is widely used in genetic analysis for human diseases. Kan has won numerous prestigious awards, including the Lasker Award and the Shaw Prize.
|
 |
Secretary-Treasurer and CEO
Margaret Foti, Ph.D., M.D. (h.c.)
American Association for Cancer Research
Philadelphia, PA
Dr. Foti has been chief executive officer of American Association for Cancer Research since 1982. She is also past president of several key cancer organizations including the National Coalition for Cancer Research, as well as other organizations including the Society for Scholarly Publishing, and the Council of Biology Editors.
|
 |
Vice-Chairman
William H. Mears, Jr., J.D., CPA
Brown Brothers Harriman Trust Co., LLC
New York, NY
Mr. Mears is regional trust head of Brown Brothers Harriman Trust, LLC. He is a past president of the Estate Planning Council of New York City and past chair of the Deferred Giving Committee of the New York Philharmonic. Mr. Mears is vice-chair of the AACR Foundation and chairperson of the Foundation's Planned Giving Committee.
Trustees
|
 |
Beverly W. Aisenbrey
Frederic W. Cook & Co., Inc.
Tarrytown, NY
Ms. Aisenbrey is a managing director in the New York office of Frederic W. Cook & Co., Inc. She has been with the firm since 1982 and is on their Board of Directors. She works with companies in designing performance-based compensation programs, primarily annual incentives, long-term incentives and stock ownership programs. Ms. Aisenbrey also writes and speaks frequently on the topic of management and board of directors' compensation and is a former trustee of Rutgers University.
|
 |
Elizabeth H. Blackburn, Ph.D.
University of California, San Francisco
San Francisco, CA
Dr. Blackburn is the Morris Herzstein professor in the Department of Biochemistry and Biophysics at the University of California, San Francisco and a non-resident fellow of the Salk Institute. Her research focuses on cancer and aging, specifically on the role of telomeres. In 2009, Dr. Blackburn shared the Nobel Prize in Medicine or Physiology for the discovery of how chromosomes are protected by telomeres and telomerase. She serves on the Scientific Advisory Committee for Stand Up To Cancer and was the 2009-2010 president of the AACR.
|
 |
Zora Brown
INTEGRIS Health
Oklahoma City, OK
Ms. Brown is founder and chairperson of Cancer Awareness Program Services (CAPS) and the Breast Cancer Resource Committee (BCRC). She is the special assistant to the CEO and director of Health and Cultural Affairs at INTEGRIS Health in Oklahoma City, Oklahoma. Ms. Brown served on the National Cancer Advisory Board from 1991 to1998. She currently serves on the boards of numerous higher education and non-profit organizations.
|
 |
Gary L. Countryman
Liberty Mutual Insurance Company
Marlborough, MA
Mr. Countryman is chairman emeritus of the board of directors of Liberty Mutual Insurance Company. Countryman spent nearly forty years with the company, attaining the positions of CEO and chairman before his retirement in 2000. In his years at Liberty Mutual, he transformed the company from a U.S. domestic property and casualty insurer into a leading international financial services group of companies. Countryman is involved at a high level in many nationally recognized organizations, including chairman of the Dana-Farber Cancer Institute.
|
 |
Raymond DuBois, M.D., Ph.D.
M. D. Anderson Cancer Center
Houston, TX
Dr. DuBois is provost and executive vice president of Academic Affairs, as well as professor of cancer biology and cancer medicine, at M. D. Anderson Cancer Center. He recently stepped down as director of the Vanderbilt-Ingram Cancer Center, where he had served as a faculty member since 1991. Dubois was the 2008-09 president of the AACR.
|
|
|
Judy E. Garber, M.D., M.P.H.
Dana-Farber Cancer Institute
Boston, MA
Dr. Garber is director of the Cancer Risk and Prevention Program at the Dana-Farber Cancer Institute, associate professor of Medicine at Harvard Medical School, and associate physician of medicine and attending physician of medical service at Brigham and Women’s Hospital. Her research focuses primarily on breast cancer risk assessment and risk reduction. Garber is the recipient of numerous professional awards, and is an elected member of the American Society for Clinical Investigation. She is a member of the Stand Up To Cancer Innovative Research Grants Review Committee, as well as several other AACR committees and editorial boards. Garber is the 2011-2012 president of the AACR.
|
 |
Nance Guilmartin
Author, Consultant
Boston, MA
Ms. Guilmartin has designed and launched such successful public service initiatives as the Designated Driver Program. She is the author of the book Healing Conversations: What to Say When You Don't Know What to Say, a collection of stories and advice to help friends, family and colleagues understand how to support one another during times of crisis and change.
|
 |
William N. Hait, M.D., Ph.D.
Ortho Biotech Oncology Research and Development
Raritan, NJ
Dr. Hait is Global Oncology Therapeutic Area Leader, Oncology for Ortho Biotech Oncology Research and Development, a unit of Johnson and Johnson Research and Development. Formerly, he was director of the Cancer Institute of New Jersey and professor of medicine and pharmacology and associate dean for oncology programs at the University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School. Dr. Hait was the 2007-2008 president of the AACR.
|
 |
Tyler E. Jacks, Ph.D.
Massachusetts Institute of Technology
Cambridge, MA
Dr. Jacks is the David H. Koch professor of biology at M.I.T., director of the David H. Koch Institute for Integrative Cancer Research at M.I.T. and an investigator with the Howard Hughes Medical Institute. He also serves on the Scientific Advisory Boards of Aveo Pharmaceuticals and the Lustgarten Foundation for Pancreatic Cancer Research. His research interests are in the genetic events that contribute to the development of cancer, particularly the oncogene K-Ras. Jacks was the 2009-2010 president of the AACR.
|
 |
V. Craig Jordan, O.B.E, Ph.D., D.Sc., F.Med.Sci.
Lombardi Comprehensive Cancer Center of Georgetown University
Washington, DC
Dr. Jordan is scientific director and vice chairman of oncology at the Lombardi Comprehensive Cancer Center of Georgetown University. Specializing in antihormonal drugs for breast cancer treatment and prevention (tamoxifen and raloxifene), he was previously vice president and research director for Medical Science and Alfred G. Knudson chair of cancer research at the Fox Chase Cancer Center, Diana Princess of Wales professor at Northwestern University and director of the Lynn Sage Breast Cancer Research Program for the Robert H. Lurie Comprehensive Cancer Center. A member of the National Academy of Sciences, Jordan is founding chairperson of the AACR Foundation President’s Circle.
|
 |
Eleanor D. Kress
Wilmington Trust Retirement and Institutional Services Co.
New York, NY
Ms. Kress is a vice president at Wilmington Trust Retirement and Institutional Services Co. She manages legal and compliance activities regarding investment vehicles for corporate and governmental retirement plans, and reviews and negotiates agreements with investment advisory firms. Kress serves as chair of Wilmington Trust’s Collective Fund Investment Sub-Committee, and as a member of the company’s Collective Investment Fund Management Committee. Kress sits on the board of directors of Cannon Point North Inc., and the North Carolina Society of New York.
|
 |
Sherry Lansing
The Sherry Lansing Foundation
Hollywood, CA
Ms. Lansing is the founder and CEO of the Sherry Lansing Foundation, a philanthropic organization focused on cancer research, health and education. Ms. Lansing was the chair of the Motion Picture Group of Paramount Pictures from 1992 to 2005. Currently, Lansing serves on the boards of Friends of Cancer Research, The Lasker Foundation, Civic Ventures, The Carter Center, and Stop Cancer. Lansing is also a regent of the University of California.
|
 |
Laurence J. Marton, M.D.
University of California, San Francisco
San Francisco, CA
Dr. Marton is an adjunct professor in the Department of Laboratory Medicine at the University of California, San Francisco, and serves as a consultant to industry, government and academic institutions. He is a leading expert with extensive experience in the fields of cell growth and drug development. Marton was previously professor and chair of the Department of Laboratory Medicine at UCSF, and dean of the School of Medicine at the University of Wisconsin. In recent years, Marton has been a founder and CEO of the SLIL Biomedical Corporation, as well as a chief scientific officer and advisor to other biopharmaceutical companies. He is a member of the board of directors of Cancer Commons and of the California Heart Center Foundation.
|
 |
Frank McCormick, Ph.D.
University of California, San Francisco Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Dr. McCormick is director of the University of California, San Francisco Helen Diller Family Comprehensive Cancer Center. He holds the E. Dixon Heise distinguished professorship in oncology and the David A. Wood distinguished professorship of tumor biology and cancer research at UCSF. Additionally, he is the associate dean of the UCSF School of Medicine. McCormick pioneered cancer research looking at the molecular basis of cancer and how genes, when mutated or expressed at high levels, help turn normal cells into oncogenes. In 1992, he founded biotech company Onyx Pharmaceuticals and developed Nexavar, which is used to treat advanced renal cell carcinoma and hepatocellular carcinoma. His current research interests center on the Ras pathway and new ways of targeting this pathway for cancer therapy. McCormick is the 2011-2012 president-elect of AACR.
|
 |
David G. Nathan, M.D.
Dana-Farber Cancer Institute
Boston, MA
Dr. Nathan is president emeritus of Dana-Farber Cancer Institute, physician-in-chief emeritus of Children's Hospital and the Robert A. Stranahan distinguished professor of pediatrics at Harvard Medical School all in Boston. He is the recipient of numerous awards, including the National Medal of Science, 1990; the Annual Award for Excellence in Clinical Research, NIH, 1996; the Henry Stratton Medal, American Society of Hematology, 1995; the John Howland Medal of the American Pediatric Society 2003, the George Kober Medal of the Association of American Physicians 2006 and the John Stearns Medal for Lifetime Achievement in Medicine of the New York Academy of Medicine 2009.
|
 |
Ellen Sigal, Ph.D.
Friends of Cancer Research
Washington, DC
Dr. Sigal is the founder and chairperson of Friends of Cancer Research. She serves on the Board of Scientific Advisors for NCI and the NIH Foundation Board, and sits on NIH’s prestigious Director’s Council of Public Representatives. Most recently, Sigal was named to the Entertainment Industry Foundation’s Oversight Committee for the Biomarker Discovery Project. She also serves on C-Change and is president of The Creative Community Task Force for Cancer Research. For her efforts, Sigal has received such awards as the 1998 AACR National Leadership Award, the 1999 Sidney Kimmel Cancer Center National Leadership Award, and the 2004 Association of American Cancer Institutes Public Service Award.
|
 |
Daniel D. Von Hoff, M.D., F.A.C.P.
TGen
Phoenix, AZ
Dr. Von Hoff is executive vice president and physician-in-chief, Clinical Research with the Translational Genomics Research Institute. He is a professor of medicine, pathology, molecular and cellular biology and director of the Arizona Health Sciences Center's Cancer Therapeutics Program and serves as chief scientific officer for U.S. Oncology. Von Hoff serves on the scientific advisory boards of numerous pharmaceutical and biotech companies. He served as the 1999-2000 president of the AACR.
|
 |
Geoffrey M. Wahl, Ph.D.
The Salk Institute for Biological Studies
La Jolla, CA
Dr. Wahl is professor in the Gene Expression Laboratory at the Salk Institute for Biological Studies. He is also adjunct professor in the biology department at the University of California, San Diego. Dr. Wahl serves on the scientific advisory boards of the San Antonio Cancer Institute, Roswell Park Institute and Canji, Inc. He served as the 2006-2007 president of the AACR.
|